IBDEI00L ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,864,1,4,0)
;;=4^C57.01
;;^UTILITY(U,$J,358.3,864,2)
;;=^5001216
;;^UTILITY(U,$J,358.3,865,0)
;;=C57.02^^10^67^4
;;^UTILITY(U,$J,358.3,865,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,865,1,3,0)
;;=3^Malignant neoplasm of left fallopian tube
;;^UTILITY(U,$J,358.3,865,1,4,0)
;;=4^C57.02
;;^UTILITY(U,$J,358.3,865,2)
;;=^5001217
;;^UTILITY(U,$J,358.3,866,0)
;;=C52.^^10^67^12
;;^UTILITY(U,$J,358.3,866,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,866,1,3,0)
;;=3^Malignant neoplasm of vagina
;;^UTILITY(U,$J,358.3,866,1,4,0)
;;=4^C52.
;;^UTILITY(U,$J,358.3,866,2)
;;=^267232
;;^UTILITY(U,$J,358.3,867,0)
;;=C51.9^^10^67^13
;;^UTILITY(U,$J,358.3,867,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,867,1,3,0)
;;=3^Malignant neoplasm of vulva, unspecified
;;^UTILITY(U,$J,358.3,867,1,4,0)
;;=4^C51.9
;;^UTILITY(U,$J,358.3,867,2)
;;=^5001202
;;^UTILITY(U,$J,358.3,868,0)
;;=C53.0^^10^67^2
;;^UTILITY(U,$J,358.3,868,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,868,1,3,0)
;;=3^Malignant neoplasm of endocervix
;;^UTILITY(U,$J,358.3,868,1,4,0)
;;=4^C53.0
;;^UTILITY(U,$J,358.3,868,2)
;;=^267215
;;^UTILITY(U,$J,358.3,869,0)
;;=C53.1^^10^67^3
;;^UTILITY(U,$J,358.3,869,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,869,1,3,0)
;;=3^Malignant neoplasm of exocervix
;;^UTILITY(U,$J,358.3,869,1,4,0)
;;=4^C53.1
;;^UTILITY(U,$J,358.3,869,2)
;;=^267216
;;^UTILITY(U,$J,358.3,870,0)
;;=C53.8^^10^67^7
;;^UTILITY(U,$J,358.3,870,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,870,1,3,0)
;;=3^Malignant neoplasm of overlapping sites of cervix uteri
;;^UTILITY(U,$J,358.3,870,1,4,0)
;;=4^C53.8
;;^UTILITY(U,$J,358.3,870,2)
;;=^5001203
;;^UTILITY(U,$J,358.3,871,0)
;;=C79.81^^10^67^14
;;^UTILITY(U,$J,358.3,871,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,871,1,3,0)
;;=3^Secondary Malignant Neoplasm Breast
;;^UTILITY(U,$J,358.3,871,1,4,0)
;;=4^C79.81
;;^UTILITY(U,$J,358.3,871,2)
;;=^267338
;;^UTILITY(U,$J,358.3,872,0)
;;=C79.82^^10^67^15
;;^UTILITY(U,$J,358.3,872,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,872,1,3,0)
;;=3^Secondary Malignant Neoplasm Genital Organs (Cervix,Fallopian Tube,Vagina)
;;^UTILITY(U,$J,358.3,872,1,4,0)
;;=4^C79.82
;;^UTILITY(U,$J,358.3,872,2)
;;=^267339
;;^UTILITY(U,$J,358.3,873,0)
;;=C79.60^^10^67^16
;;^UTILITY(U,$J,358.3,873,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,873,1,3,0)
;;=3^Secondary Malignant Neoplasm Unspec Ovary
;;^UTILITY(U,$J,358.3,873,1,4,0)
;;=4^C79.60
;;^UTILITY(U,$J,358.3,873,2)
;;=^5001352
;;^UTILITY(U,$J,358.3,874,0)
;;=D66.^^10^68^16
;;^UTILITY(U,$J,358.3,874,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,874,1,3,0)
;;=3^Hereditary factor VIII deficiency
;;^UTILITY(U,$J,358.3,874,1,4,0)
;;=4^D66.
;;^UTILITY(U,$J,358.3,874,2)
;;=^5002353
;;^UTILITY(U,$J,358.3,875,0)
;;=D67.^^10^68^15
;;^UTILITY(U,$J,358.3,875,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,875,1,3,0)
;;=3^Hereditary factor IX deficiency
;;^UTILITY(U,$J,358.3,875,1,4,0)
;;=4^D67.
;;^UTILITY(U,$J,358.3,875,2)
;;=^5002354
;;^UTILITY(U,$J,358.3,876,0)
;;=D68.1^^10^68^17
;;^UTILITY(U,$J,358.3,876,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,876,1,3,0)
;;=3^Hereditary factor XI deficiency
;;^UTILITY(U,$J,358.3,876,1,4,0)
;;=4^D68.1
;;^UTILITY(U,$J,358.3,876,2)
;;=^5002355
;;^UTILITY(U,$J,358.3,877,0)
;;=D68.2^^10^68^14
;;^UTILITY(U,$J,358.3,877,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,877,1,3,0)
;;=3^Hereditary deficiency of other clotting factors
;;^UTILITY(U,$J,358.3,877,1,4,0)
;;=4^D68.2
;;^UTILITY(U,$J,358.3,877,2)
;;=^5002356
;;^UTILITY(U,$J,358.3,878,0)
;;=D68.0^^10^68^26
;;^UTILITY(U,$J,358.3,878,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,878,1,3,0)
;;=3^Von Willebrand's disease
;;^UTILITY(U,$J,358.3,878,1,4,0)
;;=4^D68.0
;;^UTILITY(U,$J,358.3,878,2)
;;=^127267
;;^UTILITY(U,$J,358.3,879,0)
;;=D68.311^^10^68^2
;;^UTILITY(U,$J,358.3,879,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,879,1,3,0)
;;=3^Acquired hemophilia
;;^UTILITY(U,$J,358.3,879,1,4,0)
;;=4^D68.311
;;^UTILITY(U,$J,358.3,879,2)
;;=^340502
;;^UTILITY(U,$J,358.3,880,0)
;;=D68.312^^10^68^4
;;^UTILITY(U,$J,358.3,880,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,880,1,3,0)
;;=3^Antiphospholipid antibody with hemorrhagic disorder
;;^UTILITY(U,$J,358.3,880,1,4,0)
;;=4^D68.312
;;^UTILITY(U,$J,358.3,880,2)
;;=^340503
;;^UTILITY(U,$J,358.3,881,0)
;;=D68.318^^10^68^13
;;^UTILITY(U,$J,358.3,881,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,881,1,3,0)
;;=3^Hemorrhagic disord d/t intrns circ anticoag,antib,inhib NEC
;;^UTILITY(U,$J,358.3,881,1,4,0)
;;=4^D68.318
;;^UTILITY(U,$J,358.3,881,2)
;;=^340504
;;^UTILITY(U,$J,358.3,882,0)
;;=D65.^^10^68^7
;;^UTILITY(U,$J,358.3,882,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,882,1,3,0)
;;=3^Disseminated intravascular coagulation
;;^UTILITY(U,$J,358.3,882,1,4,0)
;;=4^D65.
;;^UTILITY(U,$J,358.3,882,2)
;;=^5002352
;;^UTILITY(U,$J,358.3,883,0)
;;=D68.32^^10^68^12
;;^UTILITY(U,$J,358.3,883,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,883,1,3,0)
;;=3^Hemorrhagic disord d/t extrinsic circulating anticoagulants
;;^UTILITY(U,$J,358.3,883,1,4,0)
;;=4^D68.32
;;^UTILITY(U,$J,358.3,883,2)
;;=^5002357
;;^UTILITY(U,$J,358.3,884,0)
;;=D68.4^^10^68^1
;;^UTILITY(U,$J,358.3,884,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,884,1,3,0)
;;=3^Acquired coagulation factor deficiency
;;^UTILITY(U,$J,358.3,884,1,4,0)
;;=4^D68.4
;;^UTILITY(U,$J,358.3,884,2)
;;=^2235
;;^UTILITY(U,$J,358.3,885,0)
;;=D68.8^^10^68^5
;;^UTILITY(U,$J,358.3,885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,885,1,3,0)
;;=3^Coagulation Defects NEC
;;^UTILITY(U,$J,358.3,885,1,4,0)
;;=4^D68.8
;;^UTILITY(U,$J,358.3,885,2)
;;=^5002363
;;^UTILITY(U,$J,358.3,886,0)
;;=D68.9^^10^68^6
;;^UTILITY(U,$J,358.3,886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,886,1,3,0)
;;=3^Coagulation Defects,Unspec
;;^UTILITY(U,$J,358.3,886,1,4,0)
;;=4^D68.9
;;^UTILITY(U,$J,358.3,886,2)
;;=^5002364
;;^UTILITY(U,$J,358.3,887,0)
;;=D69.1^^10^68^22
;;^UTILITY(U,$J,358.3,887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,887,1,3,0)
;;=3^Qualitative platelet defects
;;^UTILITY(U,$J,358.3,887,1,4,0)
;;=4^D69.1
;;^UTILITY(U,$J,358.3,887,2)
;;=^101922
;;^UTILITY(U,$J,358.3,888,0)
;;=D47.3^^10^68^8
;;^UTILITY(U,$J,358.3,888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,888,1,3,0)
;;=3^Essential (hemorrhagic) thrombocythemia
;;^UTILITY(U,$J,358.3,888,1,4,0)
;;=4^D47.3
;;^UTILITY(U,$J,358.3,888,2)
;;=^5002258
;;^UTILITY(U,$J,358.3,889,0)
;;=D69.0^^10^68^3
;;^UTILITY(U,$J,358.3,889,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,889,1,3,0)
;;=3^Allergic purpura
;;^UTILITY(U,$J,358.3,889,1,4,0)
;;=4^D69.0
;;^UTILITY(U,$J,358.3,889,2)
;;=^5002365
;;^UTILITY(U,$J,358.3,890,0)
;;=D69.2^^10^68^19
;;^UTILITY(U,$J,358.3,890,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,890,1,3,0)
;;=3^Nonthrombocytopenic purpura NEC
;;^UTILITY(U,$J,358.3,890,1,4,0)
;;=4^D69.2
;;^UTILITY(U,$J,358.3,890,2)
;;=^5002366
;;^UTILITY(U,$J,358.3,891,0)
;;=D69.3^^10^68^18
;;^UTILITY(U,$J,358.3,891,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,891,1,3,0)
;;=3^Immune thrombocytopenic purpura
;;^UTILITY(U,$J,358.3,891,1,4,0)
;;=4^D69.3
;;^UTILITY(U,$J,358.3,891,2)
;;=^332746
;;^UTILITY(U,$J,358.3,892,0)
;;=D69.41^^10^68^9
;;^UTILITY(U,$J,358.3,892,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,892,1,3,0)
;;=3^Evans syndrome
;;^UTILITY(U,$J,358.3,892,1,4,0)
;;=4^D69.41
;;^UTILITY(U,$J,358.3,892,2)
;;=^332747
;;^UTILITY(U,$J,358.3,893,0)
;;=D69.51^^10^68^21
;;^UTILITY(U,$J,358.3,893,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,893,1,3,0)
;;=3^Posttransfusion purpura
;;^UTILITY(U,$J,358.3,893,1,4,0)
;;=4^D69.51
;;^UTILITY(U,$J,358.3,893,2)
;;=^5002368
;;^UTILITY(U,$J,358.3,894,0)
;;=D69.59^^10^68^23
;;^UTILITY(U,$J,358.3,894,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,894,1,3,0)
;;=3^Secondary thrombocytopenia NEC
;;^UTILITY(U,$J,358.3,894,1,4,0)
;;=4^D69.59
;;^UTILITY(U,$J,358.3,894,2)
;;=^5002369
;;^UTILITY(U,$J,358.3,895,0)
;;=D69.8^^10^68^10
;;^UTILITY(U,$J,358.3,895,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,895,1,3,0)
;;=3^Hemorrhagic Conditions NEC
;;^UTILITY(U,$J,358.3,895,1,4,0)
;;=4^D69.8
;;^UTILITY(U,$J,358.3,895,2)
;;=^88074
;;^UTILITY(U,$J,358.3,896,0)
;;=D69.6^^10^68^24
;;^UTILITY(U,$J,358.3,896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,896,1,3,0)
;;=3^Thrombocytopenia, unspecified
;;^UTILITY(U,$J,358.3,896,1,4,0)
;;=4^D69.6
;;^UTILITY(U,$J,358.3,896,2)
;;=^5002370
;;^UTILITY(U,$J,358.3,897,0)
;;=D69.9^^10^68^11
;;^UTILITY(U,$J,358.3,897,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,897,1,3,0)
;;=3^Hemorrhagic condition, unspecified
;;^UTILITY(U,$J,358.3,897,1,4,0)
;;=4^D69.9
;;^UTILITY(U,$J,358.3,897,2)
;;=^5002371
;;^UTILITY(U,$J,358.3,898,0)
;;=I80.9^^10^68^20
;;^UTILITY(U,$J,358.3,898,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,898,1,3,0)
;;=3^Phlebitis and thrombophlebitis of unspecified site
;;^UTILITY(U,$J,358.3,898,1,4,0)
;;=4^I80.9
;;^UTILITY(U,$J,358.3,898,2)
;;=^93357
;;^UTILITY(U,$J,358.3,899,0)
;;=M31.10^^10^68^25
;;^UTILITY(U,$J,358.3,899,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,899,1,3,0)
;;=3^Thrombotic Microangiopathy,Unspec
;;^UTILITY(U,$J,358.3,899,1,4,0)
;;=4^M31.10
;;^UTILITY(U,$J,358.3,899,2)
;;=^5161189
;;^UTILITY(U,$J,358.3,900,0)
;;=Z31.5^^10^69^4
;;^UTILITY(U,$J,358.3,900,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,900,1,3,0)
;;=3^Genetic Counseling
;;^UTILITY(U,$J,358.3,900,1,4,0)
;;=4^Z31.5
;;^UTILITY(U,$J,358.3,900,2)
;;=^5062838
;;^UTILITY(U,$J,358.3,901,0)
;;=Z51.11^^10^69^2
;;^UTILITY(U,$J,358.3,901,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,901,1,3,0)
;;=3^Antineoplastic Chemotherapy
;;^UTILITY(U,$J,358.3,901,1,4,0)
;;=4^Z51.11
;;^UTILITY(U,$J,358.3,901,2)
;;=^5063061
;;^UTILITY(U,$J,358.3,902,0)
;;=Z71.3^^10^69^3
;;^UTILITY(U,$J,358.3,902,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,902,1,3,0)
;;=3^Dietary counseling and surveillance
;;^UTILITY(U,$J,358.3,902,1,4,0)
;;=4^Z71.3
;;^UTILITY(U,$J,358.3,902,2)
;;=^5063245
;;^UTILITY(U,$J,358.3,903,0)
;;=Z71.89^^10^69^8
;;^UTILITY(U,$J,358.3,903,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,903,1,3,0)
;;=3^Specified Counseling NEC
;;^UTILITY(U,$J,358.3,903,1,4,0)
;;=4^Z71.89
;;^UTILITY(U,$J,358.3,903,2)
;;=^5063253
;;^UTILITY(U,$J,358.3,904,0)
;;=Z51.89^^10^69^1
;;^UTILITY(U,$J,358.3,904,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,904,1,3,0)
;;=3^Aftercare NEC
;;^UTILITY(U,$J,358.3,904,1,4,0)
;;=4^Z51.89
;;^UTILITY(U,$J,358.3,904,2)
;;=^5063065
;;^UTILITY(U,$J,358.3,905,0)
;;=Z12.39^^10^69^5
;;^UTILITY(U,$J,358.3,905,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,905,1,3,0)
;;=3^Malig Neop of Breast Screening
;;^UTILITY(U,$J,358.3,905,1,4,0)
;;=4^Z12.39
;;^UTILITY(U,$J,358.3,905,2)
;;=^5062686
;;^UTILITY(U,$J,358.3,906,0)
;;=Z12.4^^10^69^6
;;^UTILITY(U,$J,358.3,906,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,906,1,3,0)
;;=3^Malig Neop of Cervix Screening
;;^UTILITY(U,$J,358.3,906,1,4,0)
;;=4^Z12.4
;;^UTILITY(U,$J,358.3,906,2)
;;=^5062687
;;^UTILITY(U,$J,358.3,907,0)
;;=Z12.12^^10^69^7
;;^UTILITY(U,$J,358.3,907,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,907,1,3,0)
;;=3^Malig Neop of Rectum Screening
;;^UTILITY(U,$J,358.3,907,1,4,0)
;;=4^Z12.12
;;^UTILITY(U,$J,358.3,907,2)
;;=^5062682
;;^UTILITY(U,$J,358.3,908,0)
;;=C61.^^10^70^10
;;^UTILITY(U,$J,358.3,908,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,908,1,3,0)
;;=3^Malignant neoplasm of prostate
;;^UTILITY(U,$J,358.3,908,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,908,2)
;;=^267239
;;^UTILITY(U,$J,358.3,909,0)
;;=C62.11^^10^70^5
;;^UTILITY(U,$J,358.3,909,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,909,1,3,0)
;;=3^Malignant neoplasm of descended right testis
;;^UTILITY(U,$J,358.3,909,1,4,0)
;;=4^C62.11
;;^UTILITY(U,$J,358.3,909,2)
;;=^5001234
;;^UTILITY(U,$J,358.3,910,0)
;;=C62.12^^10^70^4
;;^UTILITY(U,$J,358.3,910,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,910,1,3,0)
;;=3^Malignant neoplasm of descended left testis
;;^UTILITY(U,$J,358.3,910,1,4,0)
;;=4^C62.12
;;^UTILITY(U,$J,358.3,910,2)
;;=^5001235
;;^UTILITY(U,$J,358.3,911,0)
;;=C62.91^^10^70^2
;;^UTILITY(U,$J,358.3,911,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,911,1,3,0)
;;=3^Malig neoplasm of right testis, unsp descended or undescended
;;^UTILITY(U,$J,358.3,911,1,4,0)
;;=4^C62.91
;;^UTILITY(U,$J,358.3,911,2)
;;=^5001237
;;^UTILITY(U,$J,358.3,912,0)
;;=C62.92^^10^70^1
;;^UTILITY(U,$J,358.3,912,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,912,1,3,0)
;;=3^Malig neoplasm of left testis, unsp descended or undescended
;;^UTILITY(U,$J,358.3,912,1,4,0)
;;=4^C62.92
;;^UTILITY(U,$J,358.3,912,2)
;;=^5001238
;;^UTILITY(U,$J,358.3,913,0)
;;=C60.9^^10^70^9
;;^UTILITY(U,$J,358.3,913,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,913,1,3,0)
;;=3^Malignant neoplasm of penis, unspecified
;;^UTILITY(U,$J,358.3,913,1,4,0)
;;=4^C60.9
;;^UTILITY(U,$J,358.3,913,2)
;;=^5001229
;;^UTILITY(U,$J,358.3,914,0)
;;=C67.9^^10^70^3
;;^UTILITY(U,$J,358.3,914,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,914,1,3,0)
;;=3^Malignant neoplasm of bladder, unspecified
;;^UTILITY(U,$J,358.3,914,1,4,0)
;;=4^C67.9
;;^UTILITY(U,$J,358.3,914,2)
;;=^5001263
;;^UTILITY(U,$J,358.3,915,0)
;;=C64.2^^10^70^6
;;^UTILITY(U,$J,358.3,915,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,915,1,3,0)
;;=3^Malignant neoplasm of left kidney, except renal pelvis
;;^UTILITY(U,$J,358.3,915,1,4,0)
;;=4^C64.2
;;^UTILITY(U,$J,358.3,915,2)
;;=^5001249
;;^UTILITY(U,$J,358.3,916,0)
;;=C64.1^^10^70^11
;;^UTILITY(U,$J,358.3,916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,916,1,3,0)
;;=3^Malignant neoplasm of right kidney, except renal pelvis
;;^UTILITY(U,$J,358.3,916,1,4,0)
;;=4^C64.1
;;^UTILITY(U,$J,358.3,916,2)
;;=^5001248
;;^UTILITY(U,$J,358.3,917,0)
;;=C65.1^^10^70^12
;;^UTILITY(U,$J,358.3,917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,917,1,3,0)
;;=3^Malignant neoplasm of right renal pelvis
;;^UTILITY(U,$J,358.3,917,1,4,0)
;;=4^C65.1
;;^UTILITY(U,$J,358.3,917,2)
;;=^5001251
;;^UTILITY(U,$J,358.3,918,0)
;;=C65.2^^10^70^7
;;^UTILITY(U,$J,358.3,918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,918,1,3,0)
;;=3^Malignant neoplasm of left renal pelvis
;;^UTILITY(U,$J,358.3,918,1,4,0)
;;=4^C65.2
;;^UTILITY(U,$J,358.3,918,2)
;;=^5001252
;;^UTILITY(U,$J,358.3,919,0)
;;=C66.1^^10^70^13
;;^UTILITY(U,$J,358.3,919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,919,1,3,0)
;;=3^Malignant neoplasm of right ureter
;;^UTILITY(U,$J,358.3,919,1,4,0)
;;=4^C66.1
;;^UTILITY(U,$J,358.3,919,2)
;;=^5001254
;;^UTILITY(U,$J,358.3,920,0)
;;=C66.2^^10^70^8
;;^UTILITY(U,$J,358.3,920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,920,1,3,0)
;;=3^Malignant neoplasm of left ureter
;;^UTILITY(U,$J,358.3,920,1,4,0)
;;=4^C66.2
;;^UTILITY(U,$J,358.3,920,2)
;;=^5001255
;;^UTILITY(U,$J,358.3,921,0)
;;=C68.0^^10^70^14
;;^UTILITY(U,$J,358.3,921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,921,1,3,0)
;;=3^Malignant neoplasm of urethra
;;^UTILITY(U,$J,358.3,921,1,4,0)
;;=4^C68.0
;;^UTILITY(U,$J,358.3,921,2)
;;=^267266
;;^UTILITY(U,$J,358.3,922,0)
;;=C79.11^^10^70^15
;;^UTILITY(U,$J,358.3,922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,922,1,3,0)
;;=3^Secondary Malignant Neoplasm Bladder
;;^UTILITY(U,$J,358.3,922,1,4,0)
;;=4^C79.11
;;^UTILITY(U,$J,358.3,922,2)
;;=^5001346
;;^UTILITY(U,$J,358.3,923,0)
;;=C79.82^^10^70^16
;;^UTILITY(U,$J,358.3,923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,923,1,3,0)
;;=3^Secondary Malignant Neoplasm Genital Organs (Testes,Penis,Prostate)
;;^UTILITY(U,$J,358.3,923,1,4,0)
;;=4^C79.82
;;^UTILITY(U,$J,358.3,923,2)
;;=^267339
;;^UTILITY(U,$J,358.3,924,0)
;;=C79.00^^10^70^18
;;^UTILITY(U,$J,358.3,924,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,924,1,3,0)
;;=3^Secondary Malignant Neoplasm Unspec Kidney & Renal Pelvis
;;^UTILITY(U,$J,358.3,924,1,4,0)
;;=4^C79.00
;;^UTILITY(U,$J,358.3,924,2)
;;=^5001342
;;^UTILITY(U,$J,358.3,925,0)
;;=C79.19^^10^70^17
;;^UTILITY(U,$J,358.3,925,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,925,1,3,0)
;;=3^Secondary Malignant Neoplasm Oth Urinary Organs (Ureter,Urethra)
;;^UTILITY(U,$J,358.3,925,1,4,0)
;;=4^C79.19
;;^UTILITY(U,$J,358.3,925,2)
;;=^267332
;;^UTILITY(U,$J,358.3,926,0)
;;=C15.9^^10^71^9
;;^UTILITY(U,$J,358.3,926,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,926,1,3,0)
;;=3^Malignant neoplasm of esophagus, unspecified
;;^UTILITY(U,$J,358.3,926,1,4,0)
;;=4^C15.9
;;^UTILITY(U,$J,358.3,926,2)
;;=^5000919
;;^UTILITY(U,$J,358.3,927,0)
;;=C16.9^^10^71^18
;;^UTILITY(U,$J,358.3,927,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,927,1,3,0)
;;=3^Malignant neoplasm of stomach, unspecified
;;^UTILITY(U,$J,358.3,927,1,4,0)
;;=4^C16.9
;;^UTILITY(U,$J,358.3,927,2)
;;=^5000923
;;^UTILITY(U,$J,358.3,928,0)
;;=C17.9^^10^71^17
;;^UTILITY(U,$J,358.3,928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,928,1,3,0)
;;=3^Malignant neoplasm of small intestine, unspecified
;;^UTILITY(U,$J,358.3,928,1,4,0)
;;=4^C17.9
;;^UTILITY(U,$J,358.3,928,2)
;;=^5000926
;;^UTILITY(U,$J,358.3,929,0)
;;=C18.9^^10^71^8
;;^UTILITY(U,$J,358.3,929,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,929,1,3,0)
;;=3^Malignant neoplasm of colon, unspecified
;;^UTILITY(U,$J,358.3,929,1,4,0)
;;=4^C18.9
;;^UTILITY(U,$J,358.3,929,2)
;;=^5000929
;;^UTILITY(U,$J,358.3,930,0)
;;=C20.^^10^71^16
;;^UTILITY(U,$J,358.3,930,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,930,1,3,0)
;;=3^Malignant neoplasm of rectum
;;^UTILITY(U,$J,358.3,930,1,4,0)
;;=4^C20.
;;^UTILITY(U,$J,358.3,930,2)
;;=^267090
;;^UTILITY(U,$J,358.3,931,0)
;;=C21.0^^10^71^6
;;^UTILITY(U,$J,358.3,931,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,931,1,3,0)
;;=3^Malignant neoplasm of anus, unspecified
;;^UTILITY(U,$J,358.3,931,1,4,0)
;;=4^C21.0
;;^UTILITY(U,$J,358.3,931,2)
;;=^5000930
;;^UTILITY(U,$J,358.3,932,0)
;;=C22.8^^10^71^12
;;^UTILITY(U,$J,358.3,932,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,932,1,3,0)
;;=3^Malignant neoplasm of liver, primary, unspecified as to type
;;^UTILITY(U,$J,358.3,932,1,4,0)
;;=4^C22.8
;;^UTILITY(U,$J,358.3,932,2)
;;=^5000939
;;^UTILITY(U,$J,358.3,933,0)
;;=C22.7^^10^71^2
;;^UTILITY(U,$J,358.3,933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,933,1,3,0)
;;=3^Carcinomas of Liver NEC
;;^UTILITY(U,$J,358.3,933,1,4,0)
;;=4^C22.7
;;^UTILITY(U,$J,358.3,933,2)
;;=^5000938
;;^UTILITY(U,$J,358.3,934,0)
;;=C22.2^^10^71^3
;;^UTILITY(U,$J,358.3,934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,934,1,3,0)
;;=3^Hepatoblastoma
;;^UTILITY(U,$J,358.3,934,1,4,0)
;;=4^C22.2
;;^UTILITY(U,$J,358.3,934,2)
;;=^5000935
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI00L 19750 printed Nov 22, 2024@16:49:27 Page 2
IBDEI00L ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,864,1,4,0)
+2 ;;=4^C57.01
+3 ;;^UTILITY(U,$J,358.3,864,2)
+4 ;;=^5001216
+5 ;;^UTILITY(U,$J,358.3,865,0)
+6 ;;=C57.02^^10^67^4
+7 ;;^UTILITY(U,$J,358.3,865,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,865,1,3,0)
+10 ;;=3^Malignant neoplasm of left fallopian tube
+11 ;;^UTILITY(U,$J,358.3,865,1,4,0)
+12 ;;=4^C57.02
+13 ;;^UTILITY(U,$J,358.3,865,2)
+14 ;;=^5001217
+15 ;;^UTILITY(U,$J,358.3,866,0)
+16 ;;=C52.^^10^67^12
+17 ;;^UTILITY(U,$J,358.3,866,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,866,1,3,0)
+20 ;;=3^Malignant neoplasm of vagina
+21 ;;^UTILITY(U,$J,358.3,866,1,4,0)
+22 ;;=4^C52.
+23 ;;^UTILITY(U,$J,358.3,866,2)
+24 ;;=^267232
+25 ;;^UTILITY(U,$J,358.3,867,0)
+26 ;;=C51.9^^10^67^13
+27 ;;^UTILITY(U,$J,358.3,867,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,867,1,3,0)
+30 ;;=3^Malignant neoplasm of vulva, unspecified
+31 ;;^UTILITY(U,$J,358.3,867,1,4,0)
+32 ;;=4^C51.9
+33 ;;^UTILITY(U,$J,358.3,867,2)
+34 ;;=^5001202
+35 ;;^UTILITY(U,$J,358.3,868,0)
+36 ;;=C53.0^^10^67^2
+37 ;;^UTILITY(U,$J,358.3,868,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,868,1,3,0)
+40 ;;=3^Malignant neoplasm of endocervix
+41 ;;^UTILITY(U,$J,358.3,868,1,4,0)
+42 ;;=4^C53.0
+43 ;;^UTILITY(U,$J,358.3,868,2)
+44 ;;=^267215
+45 ;;^UTILITY(U,$J,358.3,869,0)
+46 ;;=C53.1^^10^67^3
+47 ;;^UTILITY(U,$J,358.3,869,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,869,1,3,0)
+50 ;;=3^Malignant neoplasm of exocervix
+51 ;;^UTILITY(U,$J,358.3,869,1,4,0)
+52 ;;=4^C53.1
+53 ;;^UTILITY(U,$J,358.3,869,2)
+54 ;;=^267216
+55 ;;^UTILITY(U,$J,358.3,870,0)
+56 ;;=C53.8^^10^67^7
+57 ;;^UTILITY(U,$J,358.3,870,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,870,1,3,0)
+60 ;;=3^Malignant neoplasm of overlapping sites of cervix uteri
+61 ;;^UTILITY(U,$J,358.3,870,1,4,0)
+62 ;;=4^C53.8
+63 ;;^UTILITY(U,$J,358.3,870,2)
+64 ;;=^5001203
+65 ;;^UTILITY(U,$J,358.3,871,0)
+66 ;;=C79.81^^10^67^14
+67 ;;^UTILITY(U,$J,358.3,871,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,871,1,3,0)
+70 ;;=3^Secondary Malignant Neoplasm Breast
+71 ;;^UTILITY(U,$J,358.3,871,1,4,0)
+72 ;;=4^C79.81
+73 ;;^UTILITY(U,$J,358.3,871,2)
+74 ;;=^267338
+75 ;;^UTILITY(U,$J,358.3,872,0)
+76 ;;=C79.82^^10^67^15
+77 ;;^UTILITY(U,$J,358.3,872,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,872,1,3,0)
+80 ;;=3^Secondary Malignant Neoplasm Genital Organs (Cervix,Fallopian Tube,Vagina)
+81 ;;^UTILITY(U,$J,358.3,872,1,4,0)
+82 ;;=4^C79.82
+83 ;;^UTILITY(U,$J,358.3,872,2)
+84 ;;=^267339
+85 ;;^UTILITY(U,$J,358.3,873,0)
+86 ;;=C79.60^^10^67^16
+87 ;;^UTILITY(U,$J,358.3,873,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,873,1,3,0)
+90 ;;=3^Secondary Malignant Neoplasm Unspec Ovary
+91 ;;^UTILITY(U,$J,358.3,873,1,4,0)
+92 ;;=4^C79.60
+93 ;;^UTILITY(U,$J,358.3,873,2)
+94 ;;=^5001352
+95 ;;^UTILITY(U,$J,358.3,874,0)
+96 ;;=D66.^^10^68^16
+97 ;;^UTILITY(U,$J,358.3,874,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,874,1,3,0)
+100 ;;=3^Hereditary factor VIII deficiency
+101 ;;^UTILITY(U,$J,358.3,874,1,4,0)
+102 ;;=4^D66.
+103 ;;^UTILITY(U,$J,358.3,874,2)
+104 ;;=^5002353
+105 ;;^UTILITY(U,$J,358.3,875,0)
+106 ;;=D67.^^10^68^15
+107 ;;^UTILITY(U,$J,358.3,875,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,875,1,3,0)
+110 ;;=3^Hereditary factor IX deficiency
+111 ;;^UTILITY(U,$J,358.3,875,1,4,0)
+112 ;;=4^D67.
+113 ;;^UTILITY(U,$J,358.3,875,2)
+114 ;;=^5002354
+115 ;;^UTILITY(U,$J,358.3,876,0)
+116 ;;=D68.1^^10^68^17
+117 ;;^UTILITY(U,$J,358.3,876,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,876,1,3,0)
+120 ;;=3^Hereditary factor XI deficiency
+121 ;;^UTILITY(U,$J,358.3,876,1,4,0)
+122 ;;=4^D68.1
+123 ;;^UTILITY(U,$J,358.3,876,2)
+124 ;;=^5002355
+125 ;;^UTILITY(U,$J,358.3,877,0)
+126 ;;=D68.2^^10^68^14
+127 ;;^UTILITY(U,$J,358.3,877,1,0)
+128 ;;=^358.31IA^4^2
+129 ;;^UTILITY(U,$J,358.3,877,1,3,0)
+130 ;;=3^Hereditary deficiency of other clotting factors
+131 ;;^UTILITY(U,$J,358.3,877,1,4,0)
+132 ;;=4^D68.2
+133 ;;^UTILITY(U,$J,358.3,877,2)
+134 ;;=^5002356
+135 ;;^UTILITY(U,$J,358.3,878,0)
+136 ;;=D68.0^^10^68^26
+137 ;;^UTILITY(U,$J,358.3,878,1,0)
+138 ;;=^358.31IA^4^2
+139 ;;^UTILITY(U,$J,358.3,878,1,3,0)
+140 ;;=3^Von Willebrand's disease
+141 ;;^UTILITY(U,$J,358.3,878,1,4,0)
+142 ;;=4^D68.0
+143 ;;^UTILITY(U,$J,358.3,878,2)
+144 ;;=^127267
+145 ;;^UTILITY(U,$J,358.3,879,0)
+146 ;;=D68.311^^10^68^2
+147 ;;^UTILITY(U,$J,358.3,879,1,0)
+148 ;;=^358.31IA^4^2
+149 ;;^UTILITY(U,$J,358.3,879,1,3,0)
+150 ;;=3^Acquired hemophilia
+151 ;;^UTILITY(U,$J,358.3,879,1,4,0)
+152 ;;=4^D68.311
+153 ;;^UTILITY(U,$J,358.3,879,2)
+154 ;;=^340502
+155 ;;^UTILITY(U,$J,358.3,880,0)
+156 ;;=D68.312^^10^68^4
+157 ;;^UTILITY(U,$J,358.3,880,1,0)
+158 ;;=^358.31IA^4^2
+159 ;;^UTILITY(U,$J,358.3,880,1,3,0)
+160 ;;=3^Antiphospholipid antibody with hemorrhagic disorder
+161 ;;^UTILITY(U,$J,358.3,880,1,4,0)
+162 ;;=4^D68.312
+163 ;;^UTILITY(U,$J,358.3,880,2)
+164 ;;=^340503
+165 ;;^UTILITY(U,$J,358.3,881,0)
+166 ;;=D68.318^^10^68^13
+167 ;;^UTILITY(U,$J,358.3,881,1,0)
+168 ;;=^358.31IA^4^2
+169 ;;^UTILITY(U,$J,358.3,881,1,3,0)
+170 ;;=3^Hemorrhagic disord d/t intrns circ anticoag,antib,inhib NEC
+171 ;;^UTILITY(U,$J,358.3,881,1,4,0)
+172 ;;=4^D68.318
+173 ;;^UTILITY(U,$J,358.3,881,2)
+174 ;;=^340504
+175 ;;^UTILITY(U,$J,358.3,882,0)
+176 ;;=D65.^^10^68^7
+177 ;;^UTILITY(U,$J,358.3,882,1,0)
+178 ;;=^358.31IA^4^2
+179 ;;^UTILITY(U,$J,358.3,882,1,3,0)
+180 ;;=3^Disseminated intravascular coagulation
+181 ;;^UTILITY(U,$J,358.3,882,1,4,0)
+182 ;;=4^D65.
+183 ;;^UTILITY(U,$J,358.3,882,2)
+184 ;;=^5002352
+185 ;;^UTILITY(U,$J,358.3,883,0)
+186 ;;=D68.32^^10^68^12
+187 ;;^UTILITY(U,$J,358.3,883,1,0)
+188 ;;=^358.31IA^4^2
+189 ;;^UTILITY(U,$J,358.3,883,1,3,0)
+190 ;;=3^Hemorrhagic disord d/t extrinsic circulating anticoagulants
+191 ;;^UTILITY(U,$J,358.3,883,1,4,0)
+192 ;;=4^D68.32
+193 ;;^UTILITY(U,$J,358.3,883,2)
+194 ;;=^5002357
+195 ;;^UTILITY(U,$J,358.3,884,0)
+196 ;;=D68.4^^10^68^1
+197 ;;^UTILITY(U,$J,358.3,884,1,0)
+198 ;;=^358.31IA^4^2
+199 ;;^UTILITY(U,$J,358.3,884,1,3,0)
+200 ;;=3^Acquired coagulation factor deficiency
+201 ;;^UTILITY(U,$J,358.3,884,1,4,0)
+202 ;;=4^D68.4
+203 ;;^UTILITY(U,$J,358.3,884,2)
+204 ;;=^2235
+205 ;;^UTILITY(U,$J,358.3,885,0)
+206 ;;=D68.8^^10^68^5
+207 ;;^UTILITY(U,$J,358.3,885,1,0)
+208 ;;=^358.31IA^4^2
+209 ;;^UTILITY(U,$J,358.3,885,1,3,0)
+210 ;;=3^Coagulation Defects NEC
+211 ;;^UTILITY(U,$J,358.3,885,1,4,0)
+212 ;;=4^D68.8
+213 ;;^UTILITY(U,$J,358.3,885,2)
+214 ;;=^5002363
+215 ;;^UTILITY(U,$J,358.3,886,0)
+216 ;;=D68.9^^10^68^6
+217 ;;^UTILITY(U,$J,358.3,886,1,0)
+218 ;;=^358.31IA^4^2
+219 ;;^UTILITY(U,$J,358.3,886,1,3,0)
+220 ;;=3^Coagulation Defects,Unspec
+221 ;;^UTILITY(U,$J,358.3,886,1,4,0)
+222 ;;=4^D68.9
+223 ;;^UTILITY(U,$J,358.3,886,2)
+224 ;;=^5002364
+225 ;;^UTILITY(U,$J,358.3,887,0)
+226 ;;=D69.1^^10^68^22
+227 ;;^UTILITY(U,$J,358.3,887,1,0)
+228 ;;=^358.31IA^4^2
+229 ;;^UTILITY(U,$J,358.3,887,1,3,0)
+230 ;;=3^Qualitative platelet defects
+231 ;;^UTILITY(U,$J,358.3,887,1,4,0)
+232 ;;=4^D69.1
+233 ;;^UTILITY(U,$J,358.3,887,2)
+234 ;;=^101922
+235 ;;^UTILITY(U,$J,358.3,888,0)
+236 ;;=D47.3^^10^68^8
+237 ;;^UTILITY(U,$J,358.3,888,1,0)
+238 ;;=^358.31IA^4^2
+239 ;;^UTILITY(U,$J,358.3,888,1,3,0)
+240 ;;=3^Essential (hemorrhagic) thrombocythemia
+241 ;;^UTILITY(U,$J,358.3,888,1,4,0)
+242 ;;=4^D47.3
+243 ;;^UTILITY(U,$J,358.3,888,2)
+244 ;;=^5002258
+245 ;;^UTILITY(U,$J,358.3,889,0)
+246 ;;=D69.0^^10^68^3
+247 ;;^UTILITY(U,$J,358.3,889,1,0)
+248 ;;=^358.31IA^4^2
+249 ;;^UTILITY(U,$J,358.3,889,1,3,0)
+250 ;;=3^Allergic purpura
+251 ;;^UTILITY(U,$J,358.3,889,1,4,0)
+252 ;;=4^D69.0
+253 ;;^UTILITY(U,$J,358.3,889,2)
+254 ;;=^5002365
+255 ;;^UTILITY(U,$J,358.3,890,0)
+256 ;;=D69.2^^10^68^19
+257 ;;^UTILITY(U,$J,358.3,890,1,0)
+258 ;;=^358.31IA^4^2
+259 ;;^UTILITY(U,$J,358.3,890,1,3,0)
+260 ;;=3^Nonthrombocytopenic purpura NEC
+261 ;;^UTILITY(U,$J,358.3,890,1,4,0)
+262 ;;=4^D69.2
+263 ;;^UTILITY(U,$J,358.3,890,2)
+264 ;;=^5002366
+265 ;;^UTILITY(U,$J,358.3,891,0)
+266 ;;=D69.3^^10^68^18
+267 ;;^UTILITY(U,$J,358.3,891,1,0)
+268 ;;=^358.31IA^4^2
+269 ;;^UTILITY(U,$J,358.3,891,1,3,0)
+270 ;;=3^Immune thrombocytopenic purpura
+271 ;;^UTILITY(U,$J,358.3,891,1,4,0)
+272 ;;=4^D69.3
+273 ;;^UTILITY(U,$J,358.3,891,2)
+274 ;;=^332746
+275 ;;^UTILITY(U,$J,358.3,892,0)
+276 ;;=D69.41^^10^68^9
+277 ;;^UTILITY(U,$J,358.3,892,1,0)
+278 ;;=^358.31IA^4^2
+279 ;;^UTILITY(U,$J,358.3,892,1,3,0)
+280 ;;=3^Evans syndrome
+281 ;;^UTILITY(U,$J,358.3,892,1,4,0)
+282 ;;=4^D69.41
+283 ;;^UTILITY(U,$J,358.3,892,2)
+284 ;;=^332747
+285 ;;^UTILITY(U,$J,358.3,893,0)
+286 ;;=D69.51^^10^68^21
+287 ;;^UTILITY(U,$J,358.3,893,1,0)
+288 ;;=^358.31IA^4^2
+289 ;;^UTILITY(U,$J,358.3,893,1,3,0)
+290 ;;=3^Posttransfusion purpura
+291 ;;^UTILITY(U,$J,358.3,893,1,4,0)
+292 ;;=4^D69.51
+293 ;;^UTILITY(U,$J,358.3,893,2)
+294 ;;=^5002368
+295 ;;^UTILITY(U,$J,358.3,894,0)
+296 ;;=D69.59^^10^68^23
+297 ;;^UTILITY(U,$J,358.3,894,1,0)
+298 ;;=^358.31IA^4^2
+299 ;;^UTILITY(U,$J,358.3,894,1,3,0)
+300 ;;=3^Secondary thrombocytopenia NEC
+301 ;;^UTILITY(U,$J,358.3,894,1,4,0)
+302 ;;=4^D69.59
+303 ;;^UTILITY(U,$J,358.3,894,2)
+304 ;;=^5002369
+305 ;;^UTILITY(U,$J,358.3,895,0)
+306 ;;=D69.8^^10^68^10
+307 ;;^UTILITY(U,$J,358.3,895,1,0)
+308 ;;=^358.31IA^4^2
+309 ;;^UTILITY(U,$J,358.3,895,1,3,0)
+310 ;;=3^Hemorrhagic Conditions NEC
+311 ;;^UTILITY(U,$J,358.3,895,1,4,0)
+312 ;;=4^D69.8
+313 ;;^UTILITY(U,$J,358.3,895,2)
+314 ;;=^88074
+315 ;;^UTILITY(U,$J,358.3,896,0)
+316 ;;=D69.6^^10^68^24
+317 ;;^UTILITY(U,$J,358.3,896,1,0)
+318 ;;=^358.31IA^4^2
+319 ;;^UTILITY(U,$J,358.3,896,1,3,0)
+320 ;;=3^Thrombocytopenia, unspecified
+321 ;;^UTILITY(U,$J,358.3,896,1,4,0)
+322 ;;=4^D69.6
+323 ;;^UTILITY(U,$J,358.3,896,2)
+324 ;;=^5002370
+325 ;;^UTILITY(U,$J,358.3,897,0)
+326 ;;=D69.9^^10^68^11
+327 ;;^UTILITY(U,$J,358.3,897,1,0)
+328 ;;=^358.31IA^4^2
+329 ;;^UTILITY(U,$J,358.3,897,1,3,0)
+330 ;;=3^Hemorrhagic condition, unspecified
+331 ;;^UTILITY(U,$J,358.3,897,1,4,0)
+332 ;;=4^D69.9
+333 ;;^UTILITY(U,$J,358.3,897,2)
+334 ;;=^5002371
+335 ;;^UTILITY(U,$J,358.3,898,0)
+336 ;;=I80.9^^10^68^20
+337 ;;^UTILITY(U,$J,358.3,898,1,0)
+338 ;;=^358.31IA^4^2
+339 ;;^UTILITY(U,$J,358.3,898,1,3,0)
+340 ;;=3^Phlebitis and thrombophlebitis of unspecified site
+341 ;;^UTILITY(U,$J,358.3,898,1,4,0)
+342 ;;=4^I80.9
+343 ;;^UTILITY(U,$J,358.3,898,2)
+344 ;;=^93357
+345 ;;^UTILITY(U,$J,358.3,899,0)
+346 ;;=M31.10^^10^68^25
+347 ;;^UTILITY(U,$J,358.3,899,1,0)
+348 ;;=^358.31IA^4^2
+349 ;;^UTILITY(U,$J,358.3,899,1,3,0)
+350 ;;=3^Thrombotic Microangiopathy,Unspec
+351 ;;^UTILITY(U,$J,358.3,899,1,4,0)
+352 ;;=4^M31.10
+353 ;;^UTILITY(U,$J,358.3,899,2)
+354 ;;=^5161189
+355 ;;^UTILITY(U,$J,358.3,900,0)
+356 ;;=Z31.5^^10^69^4
+357 ;;^UTILITY(U,$J,358.3,900,1,0)
+358 ;;=^358.31IA^4^2
+359 ;;^UTILITY(U,$J,358.3,900,1,3,0)
+360 ;;=3^Genetic Counseling
+361 ;;^UTILITY(U,$J,358.3,900,1,4,0)
+362 ;;=4^Z31.5
+363 ;;^UTILITY(U,$J,358.3,900,2)
+364 ;;=^5062838
+365 ;;^UTILITY(U,$J,358.3,901,0)
+366 ;;=Z51.11^^10^69^2
+367 ;;^UTILITY(U,$J,358.3,901,1,0)
+368 ;;=^358.31IA^4^2
+369 ;;^UTILITY(U,$J,358.3,901,1,3,0)
+370 ;;=3^Antineoplastic Chemotherapy
+371 ;;^UTILITY(U,$J,358.3,901,1,4,0)
+372 ;;=4^Z51.11
+373 ;;^UTILITY(U,$J,358.3,901,2)
+374 ;;=^5063061
+375 ;;^UTILITY(U,$J,358.3,902,0)
+376 ;;=Z71.3^^10^69^3
+377 ;;^UTILITY(U,$J,358.3,902,1,0)
+378 ;;=^358.31IA^4^2
+379 ;;^UTILITY(U,$J,358.3,902,1,3,0)
+380 ;;=3^Dietary counseling and surveillance
+381 ;;^UTILITY(U,$J,358.3,902,1,4,0)
+382 ;;=4^Z71.3
+383 ;;^UTILITY(U,$J,358.3,902,2)
+384 ;;=^5063245
+385 ;;^UTILITY(U,$J,358.3,903,0)
+386 ;;=Z71.89^^10^69^8
+387 ;;^UTILITY(U,$J,358.3,903,1,0)
+388 ;;=^358.31IA^4^2
+389 ;;^UTILITY(U,$J,358.3,903,1,3,0)
+390 ;;=3^Specified Counseling NEC
+391 ;;^UTILITY(U,$J,358.3,903,1,4,0)
+392 ;;=4^Z71.89
+393 ;;^UTILITY(U,$J,358.3,903,2)
+394 ;;=^5063253
+395 ;;^UTILITY(U,$J,358.3,904,0)
+396 ;;=Z51.89^^10^69^1
+397 ;;^UTILITY(U,$J,358.3,904,1,0)
+398 ;;=^358.31IA^4^2
+399 ;;^UTILITY(U,$J,358.3,904,1,3,0)
+400 ;;=3^Aftercare NEC
+401 ;;^UTILITY(U,$J,358.3,904,1,4,0)
+402 ;;=4^Z51.89
+403 ;;^UTILITY(U,$J,358.3,904,2)
+404 ;;=^5063065
+405 ;;^UTILITY(U,$J,358.3,905,0)
+406 ;;=Z12.39^^10^69^5
+407 ;;^UTILITY(U,$J,358.3,905,1,0)
+408 ;;=^358.31IA^4^2
+409 ;;^UTILITY(U,$J,358.3,905,1,3,0)
+410 ;;=3^Malig Neop of Breast Screening
+411 ;;^UTILITY(U,$J,358.3,905,1,4,0)
+412 ;;=4^Z12.39
+413 ;;^UTILITY(U,$J,358.3,905,2)
+414 ;;=^5062686
+415 ;;^UTILITY(U,$J,358.3,906,0)
+416 ;;=Z12.4^^10^69^6
+417 ;;^UTILITY(U,$J,358.3,906,1,0)
+418 ;;=^358.31IA^4^2
+419 ;;^UTILITY(U,$J,358.3,906,1,3,0)
+420 ;;=3^Malig Neop of Cervix Screening
+421 ;;^UTILITY(U,$J,358.3,906,1,4,0)
+422 ;;=4^Z12.4
+423 ;;^UTILITY(U,$J,358.3,906,2)
+424 ;;=^5062687
+425 ;;^UTILITY(U,$J,358.3,907,0)
+426 ;;=Z12.12^^10^69^7
+427 ;;^UTILITY(U,$J,358.3,907,1,0)
+428 ;;=^358.31IA^4^2
+429 ;;^UTILITY(U,$J,358.3,907,1,3,0)
+430 ;;=3^Malig Neop of Rectum Screening
+431 ;;^UTILITY(U,$J,358.3,907,1,4,0)
+432 ;;=4^Z12.12
+433 ;;^UTILITY(U,$J,358.3,907,2)
+434 ;;=^5062682
+435 ;;^UTILITY(U,$J,358.3,908,0)
+436 ;;=C61.^^10^70^10
+437 ;;^UTILITY(U,$J,358.3,908,1,0)
+438 ;;=^358.31IA^4^2
+439 ;;^UTILITY(U,$J,358.3,908,1,3,0)
+440 ;;=3^Malignant neoplasm of prostate
+441 ;;^UTILITY(U,$J,358.3,908,1,4,0)
+442 ;;=4^C61.
+443 ;;^UTILITY(U,$J,358.3,908,2)
+444 ;;=^267239
+445 ;;^UTILITY(U,$J,358.3,909,0)
+446 ;;=C62.11^^10^70^5
+447 ;;^UTILITY(U,$J,358.3,909,1,0)
+448 ;;=^358.31IA^4^2
+449 ;;^UTILITY(U,$J,358.3,909,1,3,0)
+450 ;;=3^Malignant neoplasm of descended right testis
+451 ;;^UTILITY(U,$J,358.3,909,1,4,0)
+452 ;;=4^C62.11
+453 ;;^UTILITY(U,$J,358.3,909,2)
+454 ;;=^5001234
+455 ;;^UTILITY(U,$J,358.3,910,0)
+456 ;;=C62.12^^10^70^4
+457 ;;^UTILITY(U,$J,358.3,910,1,0)
+458 ;;=^358.31IA^4^2
+459 ;;^UTILITY(U,$J,358.3,910,1,3,0)
+460 ;;=3^Malignant neoplasm of descended left testis
+461 ;;^UTILITY(U,$J,358.3,910,1,4,0)
+462 ;;=4^C62.12
+463 ;;^UTILITY(U,$J,358.3,910,2)
+464 ;;=^5001235
+465 ;;^UTILITY(U,$J,358.3,911,0)
+466 ;;=C62.91^^10^70^2
+467 ;;^UTILITY(U,$J,358.3,911,1,0)
+468 ;;=^358.31IA^4^2
+469 ;;^UTILITY(U,$J,358.3,911,1,3,0)
+470 ;;=3^Malig neoplasm of right testis, unsp descended or undescended
+471 ;;^UTILITY(U,$J,358.3,911,1,4,0)
+472 ;;=4^C62.91
+473 ;;^UTILITY(U,$J,358.3,911,2)
+474 ;;=^5001237
+475 ;;^UTILITY(U,$J,358.3,912,0)
+476 ;;=C62.92^^10^70^1
+477 ;;^UTILITY(U,$J,358.3,912,1,0)
+478 ;;=^358.31IA^4^2
+479 ;;^UTILITY(U,$J,358.3,912,1,3,0)
+480 ;;=3^Malig neoplasm of left testis, unsp descended or undescended
+481 ;;^UTILITY(U,$J,358.3,912,1,4,0)
+482 ;;=4^C62.92
+483 ;;^UTILITY(U,$J,358.3,912,2)
+484 ;;=^5001238
+485 ;;^UTILITY(U,$J,358.3,913,0)
+486 ;;=C60.9^^10^70^9
+487 ;;^UTILITY(U,$J,358.3,913,1,0)
+488 ;;=^358.31IA^4^2
+489 ;;^UTILITY(U,$J,358.3,913,1,3,0)
+490 ;;=3^Malignant neoplasm of penis, unspecified
+491 ;;^UTILITY(U,$J,358.3,913,1,4,0)
+492 ;;=4^C60.9
+493 ;;^UTILITY(U,$J,358.3,913,2)
+494 ;;=^5001229
+495 ;;^UTILITY(U,$J,358.3,914,0)
+496 ;;=C67.9^^10^70^3
+497 ;;^UTILITY(U,$J,358.3,914,1,0)
+498 ;;=^358.31IA^4^2
+499 ;;^UTILITY(U,$J,358.3,914,1,3,0)
+500 ;;=3^Malignant neoplasm of bladder, unspecified
+501 ;;^UTILITY(U,$J,358.3,914,1,4,0)
+502 ;;=4^C67.9
+503 ;;^UTILITY(U,$J,358.3,914,2)
+504 ;;=^5001263
+505 ;;^UTILITY(U,$J,358.3,915,0)
+506 ;;=C64.2^^10^70^6
+507 ;;^UTILITY(U,$J,358.3,915,1,0)
+508 ;;=^358.31IA^4^2
+509 ;;^UTILITY(U,$J,358.3,915,1,3,0)
+510 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
+511 ;;^UTILITY(U,$J,358.3,915,1,4,0)
+512 ;;=4^C64.2
+513 ;;^UTILITY(U,$J,358.3,915,2)
+514 ;;=^5001249
+515 ;;^UTILITY(U,$J,358.3,916,0)
+516 ;;=C64.1^^10^70^11
+517 ;;^UTILITY(U,$J,358.3,916,1,0)
+518 ;;=^358.31IA^4^2
+519 ;;^UTILITY(U,$J,358.3,916,1,3,0)
+520 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
+521 ;;^UTILITY(U,$J,358.3,916,1,4,0)
+522 ;;=4^C64.1
+523 ;;^UTILITY(U,$J,358.3,916,2)
+524 ;;=^5001248
+525 ;;^UTILITY(U,$J,358.3,917,0)
+526 ;;=C65.1^^10^70^12
+527 ;;^UTILITY(U,$J,358.3,917,1,0)
+528 ;;=^358.31IA^4^2
+529 ;;^UTILITY(U,$J,358.3,917,1,3,0)
+530 ;;=3^Malignant neoplasm of right renal pelvis
+531 ;;^UTILITY(U,$J,358.3,917,1,4,0)
+532 ;;=4^C65.1
+533 ;;^UTILITY(U,$J,358.3,917,2)
+534 ;;=^5001251
+535 ;;^UTILITY(U,$J,358.3,918,0)
+536 ;;=C65.2^^10^70^7
+537 ;;^UTILITY(U,$J,358.3,918,1,0)
+538 ;;=^358.31IA^4^2
+539 ;;^UTILITY(U,$J,358.3,918,1,3,0)
+540 ;;=3^Malignant neoplasm of left renal pelvis
+541 ;;^UTILITY(U,$J,358.3,918,1,4,0)
+542 ;;=4^C65.2
+543 ;;^UTILITY(U,$J,358.3,918,2)
+544 ;;=^5001252
+545 ;;^UTILITY(U,$J,358.3,919,0)
+546 ;;=C66.1^^10^70^13
+547 ;;^UTILITY(U,$J,358.3,919,1,0)
+548 ;;=^358.31IA^4^2
+549 ;;^UTILITY(U,$J,358.3,919,1,3,0)
+550 ;;=3^Malignant neoplasm of right ureter
+551 ;;^UTILITY(U,$J,358.3,919,1,4,0)
+552 ;;=4^C66.1
+553 ;;^UTILITY(U,$J,358.3,919,2)
+554 ;;=^5001254
+555 ;;^UTILITY(U,$J,358.3,920,0)
+556 ;;=C66.2^^10^70^8
+557 ;;^UTILITY(U,$J,358.3,920,1,0)
+558 ;;=^358.31IA^4^2
+559 ;;^UTILITY(U,$J,358.3,920,1,3,0)
+560 ;;=3^Malignant neoplasm of left ureter
+561 ;;^UTILITY(U,$J,358.3,920,1,4,0)
+562 ;;=4^C66.2
+563 ;;^UTILITY(U,$J,358.3,920,2)
+564 ;;=^5001255
+565 ;;^UTILITY(U,$J,358.3,921,0)
+566 ;;=C68.0^^10^70^14
+567 ;;^UTILITY(U,$J,358.3,921,1,0)
+568 ;;=^358.31IA^4^2
+569 ;;^UTILITY(U,$J,358.3,921,1,3,0)
+570 ;;=3^Malignant neoplasm of urethra
+571 ;;^UTILITY(U,$J,358.3,921,1,4,0)
+572 ;;=4^C68.0
+573 ;;^UTILITY(U,$J,358.3,921,2)
+574 ;;=^267266
+575 ;;^UTILITY(U,$J,358.3,922,0)
+576 ;;=C79.11^^10^70^15
+577 ;;^UTILITY(U,$J,358.3,922,1,0)
+578 ;;=^358.31IA^4^2
+579 ;;^UTILITY(U,$J,358.3,922,1,3,0)
+580 ;;=3^Secondary Malignant Neoplasm Bladder
+581 ;;^UTILITY(U,$J,358.3,922,1,4,0)
+582 ;;=4^C79.11
+583 ;;^UTILITY(U,$J,358.3,922,2)
+584 ;;=^5001346
+585 ;;^UTILITY(U,$J,358.3,923,0)
+586 ;;=C79.82^^10^70^16
+587 ;;^UTILITY(U,$J,358.3,923,1,0)
+588 ;;=^358.31IA^4^2
+589 ;;^UTILITY(U,$J,358.3,923,1,3,0)
+590 ;;=3^Secondary Malignant Neoplasm Genital Organs (Testes,Penis,Prostate)
+591 ;;^UTILITY(U,$J,358.3,923,1,4,0)
+592 ;;=4^C79.82
+593 ;;^UTILITY(U,$J,358.3,923,2)
+594 ;;=^267339
+595 ;;^UTILITY(U,$J,358.3,924,0)
+596 ;;=C79.00^^10^70^18
+597 ;;^UTILITY(U,$J,358.3,924,1,0)
+598 ;;=^358.31IA^4^2
+599 ;;^UTILITY(U,$J,358.3,924,1,3,0)
+600 ;;=3^Secondary Malignant Neoplasm Unspec Kidney & Renal Pelvis
+601 ;;^UTILITY(U,$J,358.3,924,1,4,0)
+602 ;;=4^C79.00
+603 ;;^UTILITY(U,$J,358.3,924,2)
+604 ;;=^5001342
+605 ;;^UTILITY(U,$J,358.3,925,0)
+606 ;;=C79.19^^10^70^17
+607 ;;^UTILITY(U,$J,358.3,925,1,0)
+608 ;;=^358.31IA^4^2
+609 ;;^UTILITY(U,$J,358.3,925,1,3,0)
+610 ;;=3^Secondary Malignant Neoplasm Oth Urinary Organs (Ureter,Urethra)
+611 ;;^UTILITY(U,$J,358.3,925,1,4,0)
+612 ;;=4^C79.19
+613 ;;^UTILITY(U,$J,358.3,925,2)
+614 ;;=^267332
+615 ;;^UTILITY(U,$J,358.3,926,0)
+616 ;;=C15.9^^10^71^9
+617 ;;^UTILITY(U,$J,358.3,926,1,0)
+618 ;;=^358.31IA^4^2
+619 ;;^UTILITY(U,$J,358.3,926,1,3,0)
+620 ;;=3^Malignant neoplasm of esophagus, unspecified
+621 ;;^UTILITY(U,$J,358.3,926,1,4,0)
+622 ;;=4^C15.9
+623 ;;^UTILITY(U,$J,358.3,926,2)
+624 ;;=^5000919
+625 ;;^UTILITY(U,$J,358.3,927,0)
+626 ;;=C16.9^^10^71^18
+627 ;;^UTILITY(U,$J,358.3,927,1,0)
+628 ;;=^358.31IA^4^2
+629 ;;^UTILITY(U,$J,358.3,927,1,3,0)
+630 ;;=3^Malignant neoplasm of stomach, unspecified
+631 ;;^UTILITY(U,$J,358.3,927,1,4,0)
+632 ;;=4^C16.9
+633 ;;^UTILITY(U,$J,358.3,927,2)
+634 ;;=^5000923
+635 ;;^UTILITY(U,$J,358.3,928,0)
+636 ;;=C17.9^^10^71^17
+637 ;;^UTILITY(U,$J,358.3,928,1,0)
+638 ;;=^358.31IA^4^2
+639 ;;^UTILITY(U,$J,358.3,928,1,3,0)
+640 ;;=3^Malignant neoplasm of small intestine, unspecified
+641 ;;^UTILITY(U,$J,358.3,928,1,4,0)
+642 ;;=4^C17.9
+643 ;;^UTILITY(U,$J,358.3,928,2)
+644 ;;=^5000926
+645 ;;^UTILITY(U,$J,358.3,929,0)
+646 ;;=C18.9^^10^71^8
+647 ;;^UTILITY(U,$J,358.3,929,1,0)
+648 ;;=^358.31IA^4^2
+649 ;;^UTILITY(U,$J,358.3,929,1,3,0)
+650 ;;=3^Malignant neoplasm of colon, unspecified
+651 ;;^UTILITY(U,$J,358.3,929,1,4,0)
+652 ;;=4^C18.9
+653 ;;^UTILITY(U,$J,358.3,929,2)
+654 ;;=^5000929
+655 ;;^UTILITY(U,$J,358.3,930,0)
+656 ;;=C20.^^10^71^16
+657 ;;^UTILITY(U,$J,358.3,930,1,0)
+658 ;;=^358.31IA^4^2
+659 ;;^UTILITY(U,$J,358.3,930,1,3,0)
+660 ;;=3^Malignant neoplasm of rectum
+661 ;;^UTILITY(U,$J,358.3,930,1,4,0)
+662 ;;=4^C20.
+663 ;;^UTILITY(U,$J,358.3,930,2)
+664 ;;=^267090
+665 ;;^UTILITY(U,$J,358.3,931,0)
+666 ;;=C21.0^^10^71^6
+667 ;;^UTILITY(U,$J,358.3,931,1,0)
+668 ;;=^358.31IA^4^2
+669 ;;^UTILITY(U,$J,358.3,931,1,3,0)
+670 ;;=3^Malignant neoplasm of anus, unspecified
+671 ;;^UTILITY(U,$J,358.3,931,1,4,0)
+672 ;;=4^C21.0
+673 ;;^UTILITY(U,$J,358.3,931,2)
+674 ;;=^5000930
+675 ;;^UTILITY(U,$J,358.3,932,0)
+676 ;;=C22.8^^10^71^12
+677 ;;^UTILITY(U,$J,358.3,932,1,0)
+678 ;;=^358.31IA^4^2
+679 ;;^UTILITY(U,$J,358.3,932,1,3,0)
+680 ;;=3^Malignant neoplasm of liver, primary, unspecified as to type
+681 ;;^UTILITY(U,$J,358.3,932,1,4,0)
+682 ;;=4^C22.8
+683 ;;^UTILITY(U,$J,358.3,932,2)
+684 ;;=^5000939
+685 ;;^UTILITY(U,$J,358.3,933,0)
+686 ;;=C22.7^^10^71^2
+687 ;;^UTILITY(U,$J,358.3,933,1,0)
+688 ;;=^358.31IA^4^2
+689 ;;^UTILITY(U,$J,358.3,933,1,3,0)
+690 ;;=3^Carcinomas of Liver NEC
+691 ;;^UTILITY(U,$J,358.3,933,1,4,0)
+692 ;;=4^C22.7
+693 ;;^UTILITY(U,$J,358.3,933,2)
+694 ;;=^5000938
+695 ;;^UTILITY(U,$J,358.3,934,0)
+696 ;;=C22.2^^10^71^3
+697 ;;^UTILITY(U,$J,358.3,934,1,0)
+698 ;;=^358.31IA^4^2
+699 ;;^UTILITY(U,$J,358.3,934,1,3,0)
+700 ;;=3^Hepatoblastoma
+701 ;;^UTILITY(U,$J,358.3,934,1,4,0)
+702 ;;=4^C22.2
+703 ;;^UTILITY(U,$J,358.3,934,2)
+704 ;;=^5000935
